Katharina Bell
About
In The Last Decade
Katharina Bell
48 papers receiving 786 citations
Peers
Comparison fields: 5 of 69
- Ophthalmology 596
- Molecular Biology 342
- Radiology, Nuclear Medicine and Imaging 201
- Public Health, Environmental and Occupational Health 114
- Neurology 109
Countries citing papers authored by Katharina Bell
This map shows the geographic impact of Katharina Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Bell more than expected).
Fields of papers citing papers by Katharina Bell
This network shows the impact of papers produced by Katharina Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Bell. The network helps show where Katharina Bell may publish in the future.
Co-authorship network of co-authors of Katharina Bell
This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Bell. A scholar is included among the top collaborators of Katharina Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Bell. Katharina Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 33 | |
| 6 | 31 | |
| 7 | 24 | |
| 8 | 6 | |
| 9 | 6 | |
| 10 | 12 | |
| 11 | 9 | |
| 12 | Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery | 3 |
| 13 | 22 | |
| 14 | 14 | |
| 15 | 57 | |
| 16 | 9 | |
| 17 | 24 | |
| 18 | Down Regulation Of 14-3-3 Ab In Glaucoma Patients Could Lead To Loss Of Protective Effects | 2 |
| 19 | 21 | |
| 20 | 28 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.